BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21124317)

  • 1. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
    Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
    Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
    Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
    Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
    He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
    Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
    Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
    PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
    Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
    J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma.
    Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H
    Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect Down-regulation of Tumor-suppressive
    Saeki N; Saito A; Sugaya Y; Amemiya M; Sasaki H
    Cancer Genomics Proteomics; 2018; 15(5):413-420. PubMed ID: 30194082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
    Zhu S; Zhang X; Weichert-Leahey N; Dong Z; Zhang C; Lopez G; Tao T; He S; Wood AC; Oldridge D; Ung CY; van Ree JH; Khan A; Salazar BM; Lummertz da Rocha E; Zimmerman MW; Guo F; Cao H; Hou X; Weroha SJ; Perez-Atayde AR; Neuberg DS; Meves A; McNiven MA; van Deursen JM; Li H; Maris JM; Look AT
    Cancer Cell; 2017 Sep; 32(3):310-323.e5. PubMed ID: 28867147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
    Tse E; Smith AJ; Hunt S; Lavenir I; Forster A; Warren AJ; Grutz G; Foroni L; Carlton MB; Colledge WH; Boehm T; Rabbitts TH
    Mol Cell Biol; 2004 Mar; 24(5):2063-73. PubMed ID: 14966285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and genomics of neuroblastoma.
    Capasso M; Diskin SJ
    Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
    Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
    Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
    Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
    Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-β1 induced LMO1 via control of let-7 expression.
    Wang XH; Wu HY; Gao J; Wang XH; Gao TH; Zhang SF
    Brain Res; 2019 Feb; 1704():219-228. PubMed ID: 30321496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
    Nguyen le B; Diskin SJ; Capasso M; Wang K; Diamond MA; Glessner J; Kim C; Attiyeh EF; Mosse YP; Cole K; Iolascon A; Devoto M; Hakonarson H; Li HK; Maris JM
    PLoS Genet; 2011 Mar; 7(3):e1002026. PubMed ID: 21436895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The highly related LIM factors, LMO1, LMO3 and LMO4, play different roles in the regulation of the pituitary glycoprotein hormone alpha-subunit (alpha GSU) gene.
    Susa T; Ishikawa A; Cai LY; Kato T; Matsumoto K; Kitahara K; Kurokawa R; Ono T; Kato Y
    Biosci Rep; 2009 Oct; 30(1):51-8. PubMed ID: 19228115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
    Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
    Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.
    Zhang Y; Yang J; Wang J; Guo H; Jing N
    Med Oncol; 2014 Aug; 31(8):99. PubMed ID: 25037573
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    He L; Zhu J; Han F; Tang Y; Zhou C; Dai J; Wang Y; Zhou H; He J; Wu H
    Front Oncol; 2018; 8():468. PubMed ID: 30406033
    [No Abstract]   [Full Text] [Related]  

  • 20. Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).
    Beuten J; Gelfond JA; Piwkham D; Pollock BH; Winick NJ; Collier AB; Tomlinson GE
    Carcinogenesis; 2011 Sep; 32(9):1349-53. PubMed ID: 21602560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.